Angiogenesis detected after embolic stroke in rat brain using magnetic resonance T2*WI

Stroke. 2008 May;39(5):1563-8. doi: 10.1161/STROKEAHA.107.502146. Epub 2008 Mar 20.

Abstract

Background and purpose: This study uses T(2)* weighted imaging (T2*WI) to measure the temporal evolution of cerebral angiogenesis in rats subjected to embolic stroke up to 6 weeks after stroke onset with or without sildenafil treatment. Method- Male Wistar rats were subjected to embolic stroke and treated with saline (n=10) or with sildenafil (n=11), with treatment initiated at 24 hours and continued daily for 7 days after onset of ischemia. T2*WI measurements were performed at 24 hours after embolization and weekly up to 6 weeks using a 7-Tesla system. Histological measurements were obtained at 6 weeks after MRI scans.

Results: Using T2*WI, cerebral angiogenesis was detected starting from 4 weeks and from 2 weeks after onset of embolic stroke in saline and sildenafil treated rats, respectively. Significant differences in the temporal and spatial features of angiogenesis after embolic stroke up to 6 weeks after onset of stroke were found between saline and sildenafil treated rats and were identified with T2*WI. MRI permeability parameter, K(i), complementarily detected angiogenesis after ischemia in embolic stroke rats. Sildenafil treatment of stroke rats significantly enhanced the angiogenesis, as confirmed histologically.

Conclusions: T2*WI can quantitatively measure the temporal evolution of angiogenesis in rats subjected to embolic stroke. Compared to control rats, sildenafil treatment significantly increased angiogenesis in treated animals up to 6 weeks after stroke.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Brain / blood supply
  • Brain / drug effects
  • Brain Mapping / methods
  • Cerebral Arteries / anatomy & histology
  • Cerebral Arteries / drug effects*
  • Diffusion Magnetic Resonance Imaging / methods
  • Disease Models, Animal
  • Intracranial Embolism / drug therapy*
  • Intracranial Embolism / pathology
  • Intracranial Embolism / physiopathology
  • Male
  • Microcirculation / anatomy & histology
  • Microcirculation / drug effects
  • Neovascularization, Physiologic / drug effects*
  • Piperazines / pharmacology*
  • Piperazines / therapeutic use
  • Predictive Value of Tests
  • Purines / pharmacology
  • Purines / therapeutic use
  • Rats
  • Rats, Wistar
  • Recovery of Function / drug effects
  • Sildenafil Citrate
  • Stroke / drug therapy*
  • Stroke / pathology
  • Stroke / physiopathology
  • Sulfones / pharmacology*
  • Sulfones / therapeutic use
  • Time Factors
  • Treatment Outcome
  • Vasodilator Agents / pharmacology
  • Vasodilator Agents / therapeutic use

Substances

  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate

Grants and funding